Care Fusion Rx merges with Reliant Healthcare to enhance infusion therapy accessibility, supported by Shore Capital Partners.
Information on the Target
Care Fusion Rx, headquartered in Garden Grove, California, is a specialist infusion pharmacy that focuses on chronic intravenous immunoglobulin (IVIG) and biologic therapies. The company prioritizes the provision of consistent access to vital infusion treatments for patients suffering from chronic and rare diseases. Established in 2020, Care Fusion Rx has quickly made a name for itself by partnering with healthcare providers and payors to enhance the patient experience.
Reliant Healthcare, founded in 2008, is an independent provider of home infusion therapy and operates 14 ambulatory infusion centers (AICs) along with several specialty pharmacies across Louisiana, Texas, and Oklahoma. Reliant is dedicated to high-quality accessible infusion care for patients with complex conditions, significantly improving patient outcomes and overall quality of life.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target’s Specific Country
The infusion therapy market in the United States has been experiencing significant growth, driven by increasing incidences of chronic diseases and the need for advanced medical treatments. Patients now demand more accessible
Similar Deals
Novartis AG → Avidity Biosciences, Inc.
2026
XenoTherapeutics, Inc. → Repare Therapeutics Inc.
2026
MSD (Merck & Co., Inc.) → Cidara Therapeutics, Inc.
2026
RWJBarnabas Health → Englewood Health
2026
Reliant Healthcare
invested in
Care Fusion Rx
in 2025
in a Merger deal